Evidence map›Paper›PMID 38363197›Full record

ReviewRadiology. Imaging cancer2024

Multimodality Imaging to Direct Management of Primary and Recurrent Rectal Adenocarcinoma Beyond the Total Mesorectal Excision Plane.

Joshua D Shur, Sheng Qiu, Edward Johnston, Diana Tait, Nicos Fotiadis, Christos Kontovounisios, Shahnawaz Rasheed, Paris Tekkis, Angela Riddell, Dow-Mu Koh

Open access · diamondAbstract readReview
In one paragraph

Review in Radiology. Imaging cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Joshua D ShurFrom the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.).ORCID 0000-0002-4569-4785
Sheng QiuFrom the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.).ORCID 0000-0001-8699-4621
Edward JohnstonFrom the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.).ORCID 0000-0002-8504-2968
Diana TaitFrom the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.).
Nicos FotiadisFrom the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.).
Christos KontovounisiosFrom the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.).
Shahnawaz RasheedFrom the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.).
Paris TekkisFrom the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.).
Angela RiddellFrom the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.).ORCID 0000-0002-9226-2408
Dow-Mu KohFrom the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.).
Royal Marsden NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rectal tumors extending beyond the total mesorectal excision (TME) plane (beyond-TME) require particular multidisciplinary expertise and oncologic considerations when planning treatment. Imaging is used at all stages of the pathway, such as local tumor staging/restaging, creating an imaging-based "roadmap" to plan surgery for optimal tumor clearance, identifying treatment-related complications, which may be suitable for radiology-guided intervention, and to detect recurrent or metastatic disease, which may be suitable for radiology-guided ablative therapies. Beyond-TME and exenterative surgery have gained acceptance as potentially curative procedures for advanced tumors. Understanding the role, techniques, and pitfalls of current imaging techniques is important for both radiologists involved in the treatment of these patients and general radiologists who may encounter patients undergoing surveillance or patients presenting with surgical complications or intercurrent abdominal pathology. This review aims to outline the current and emerging roles of imaging in patients with beyond-TME and recurrent rectal malignancy, focusing on practical tips for image interpretation and surgical planning in the beyond-TME setting.

Indexed as

AdenocarcinomaRectal NeoplasmsHumansMultimodal ImagingNeoplasm Recurrence, LocalRectumAbdomen/GIOncologyRectum

Identifiers

PMID38363197
PMCPMC10988347
OpenAlexW4391907710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.